Precision patient care starts with vascular health monitoring.  
Read More

Why Measure Central Aortic Blood Pressure?

Cardiovascular disease is the leading cause of death worldwide — and elevated blood pressure is the clearest modifiable risk factor. Extensive research shows that central aortic blood pressure measurement, which is the pressure measured at the heart, offers complementary data to brachial pressure measurement that can help health professionals optimize hypertension treatment.


Read More

ATCOR Medical Reimbursement Guide

Established by the AMA in 2016, the SphygmoCor® Pulse Wave Analysis (PWA) procedure coding is reported using the CPT® Code 93050 and outlined in the ATCOR Reimbursement Guide.

Click here to download.

Get in touch with us



    Precision patient care starts with vascular health monitoring.
    Read More
    Why Measure Central Aortic Blood Pressure?

    Cardiovascular disease is the leading cause of death worldwide — and elevated blood pressure is the clearest modifiable risk factor. Extensive research shows that central aortic blood pressure measurement, which is the pressure measured at the heart, offers complementary data to brachial pressure measurement that can help health professionals optimize hypertension treatment.


    Read More

    ATCOR Medical Reimbursement Guide

    Established by the AMA in 2016, the SphygmoCor® Pulse Wave Analysis (PWA) procedure coding is reported using the CPT® Code 93050 and outlined in the ATCOR Reimbursement Guide.

    Click here to download.

    Get in touch with us


      See How Dr. Hunter Champion Uses ATCOR's SphygmoCor®
      to Personalize Hypertension Treatment

       
      Dr_Hunter_Champion_newlogo
       
      "You really can't practice good clinical medicine now without measuring central blood pressure. You can’t predict risk. You can’t predict goals. You can’t predict treatment. You don’t know how stiff the arteries are. You just have to have it.”

      Mark Houston
      MD, MS, MSc, FACP, FAHA, FASH, FACN, ABAARM, FAARM, DABC
      Director, Hypertension Institute, Nashville, TN

      “I use SphygmoCor in my preventive cardiology practice—it’s an integral component of my cardiovascular risk assessment.”


      Lee Marcus
      MD, MS, FACC
      Preventive Cardiology of New York, Somers, NY

      Pressure Wave Form Analysis (PWA) Explained

      ATCOR’s SphygmoCor® XCEL PWA (pulse wave analysis) uses a standard brachial cuff to measure brachial systolic and diastolic pressures and capture a brachial waveform. The brachial waveform is then analyzed to provide a central aortic waveform. Noninvasive central blood pressure measurements such as central aortic systolic blood pressure, central pulse pressure, and an aortic augmentation index (AIx) are also reported.

      Two patients with equivalent brachial pressures (Figure 1) but with significantly different central arterial pressure waveforms (Figure 2). The difference in waveform shapes, due to differences in arterial stiffness and the effects of wave reflections, affect the aortic but not the brachial systolic and pulse pressures.
      SphygmoCor® at a Glance

      All “Top 20 Hospitals” use SphygmoCor technology to measure central blood pressure (cBP)



      1,400+ studies using the SphygmoCor technology have been published in peer-reviewed clinical publications.


      8 out of Top 10 Pharma companies have used SphygmoCor technology in their clinical trials



      Over 11,000 patients have been tested with SphygmoCor technology in pharmaceutical trials